Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
This is a 48 week study for HIV-infected patients who have failed several regimens including
PI's, NNRTs and NRTIs. Patients will be randomly selected to be in 1 of 4 groups. Three of
the 4 groups will contain capravirine in different doses combined with Kaletra and
nucleosides and one of the groups will be a combination of Kaletra and nucleosides without
the capravirine.